A prominent child psychiatrist, already embroiled in two other controversies, told Johnson & Johnson that planned studies of its medicines in children would yield results benefiting the company.

A prominent child psychiatrist, already embroiled in two other controversies, told Johnson & Johnson that planned studies of its medicines in children would yield results benefiting the company.

A prominent child psychiatrist, already embroiled in two other controversies, told Johnson & Johnson that planned studies of its medicines in children would yield results benefiting the company.

Eli Lilly , Johnson & Johnson and other drugmakers misled consumers about medicines to treat attention deficit disorder in various sales pitches, US regulators said in letters released on Friday.

Eli Lilly , Johnson & Johnson and other drugmakers misled consumers about medicines to treat attention deficit disorder in various sales pitches, US regulators said in letters released on Friday.